Clinical Trial Update: SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

View source ↗

Summary

The SPECTAlung thoracic-tumor screening program has completed, documenting screening patients with lung cancer, malignant pleural mesothelioma, and thymic malig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Malignant Pleural Mesothelioma
• Thymic Malignancies

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Any Stage of Lung Cancer (Any Histotype), Any Stage of Malignant Pleural Mesothelioma | Status: COMPLETED